Phase I/II study of bortezomib in combination with carboplatin and bevacizumab as first line therapy in patients with advanced non-small cell lung cancer (NSCLC)

Por Piperdi, Bilal, Walsh, William V, Bradley, Kendra, Zhou, Zheng, Bathini, Venu, Hanrahan-Boshes, Meredith, Hutchinson, Lloyd, Perez-Soler, Roman
Publicado em 2012

A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma

Por Cetin, Volkan, Piperdi, Bilal, Bathini, Venu, Walsh, William V., Yunus, Shakeeb, Tseng, Jennifer F., Whalen, Giles F., Wassef, Wahid Y., Kadish, Sidney P., FitzGerald, Thomas J., Mikule, Christine, Wang, Yuxia, Grossman, Steven R.
Publicado em 2013

Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non–small-cell Lung Cancer

Por Li, Tianhong, Piperdi, Bilal, Walsh, William V., Kim, Mimi, Beckett, Laurel A., Gucalp, Rasim, Haigentz, Missak, Bathini, Venu G., Wen, Huiyu, Zhou, Kaili, Pasquinelli, Patricia B., Gajavelli, Srikanth, Sreedhara, Meera, Xie, Xianhong, Lara, Primo N., Gandara, David R., Perez-Soler, Roman
Publicado no Clin Lung Cancer (2016)